Healthcare

• FY26Revenueremained near AUD 19.8 million, broadly consistent with the company’s reported prior financial year.

• Arrotex will handle product registration, market access,Marketingand sales costs within the licensed territories.

• The indicated result represented around 18% growth on FY25 and remained subject to audit at announcement.

Pharmx released its FY26 results and accompanying investor presentation on 27 August 2026. Earlier in 2026, the company described a strategic alliance with Sigma Healthcare as part of its market development.

On 5 October, Hydrix announced delivery of its first prototype to NIOA for a counter-drone program. Prototype delivery is an important development step because it moves an engineering assignment beyond design work. It does not, however, mean final product qualification or scaled production has …

In August 2026, Talius announced a three-year AUD 1.65 mn agreement with Adventist Retirement Plus. The contract followed a separate three-year arrangement with Longridge Aged Care announced in July.

Pharmx released its FY26 results and accompanying investor presentation on 27 August 2026. Earlier in 2026, the company described a strategic alliance with Sigma Healthcare as part of its market development.